C
Catalyst Pharmaceuticals D
D
CPRX
20.980
USD
-0.04
(-0.19%)
مغلق
حجم التداول
34,039
الربح لكل سهم
2
العائد الربحي
-
P/E
13
حجم السوق
2,559,038,689
الأخبار المقالات
العنوان: Catalyst Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).